Q: If MNTA gets FDA approval for an interchangeable Humira FoB by the end of 2018 and no other company achieves this, will MNTA and ABBV reach a settlement enabling MNTA to launch before 2022?
a) Almost certainly b) Likely c) Unlikely but possible d) No chance